MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0001085
Rouzel Pharma Private Limited - pharma in Manimajra, Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.56 Cr
▲ 8% YoY
Net profit · FY 2024
₹22.2 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹89.59 Lakh
EBITDA margin 6.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹1.67 Cr
Satisfied ₹40 Lakh
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Rouzel Pharma Private Limited
Data last updated:
Rouzel Pharma Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC032830. Its GSTIN is 06AAFCR2257Q1ZW (Haryana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Vikas Sharma (Managing Director) and Vivek Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 296 – 297 Ground Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.56 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹22.2 Lakh (net margin 1.6%) and EBITDA of ₹89.59 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
The company is associated with 1 brand: Rouzel Pharma. As per MCA filings, the company has open charges of ₹1.67 Cr and satisfied charges of ₹40 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.
Rouzel Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0001085). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rouzelpharma.in.
Company Details of Rouzel Pharma Private Limited
CIN U24232CH2011PTC032830
Registration Number 032830
Incorporation Date 23 March 2011
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0001085
Recognitions & Rankings of Rouzel Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressScf 296 – 297 Ground Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Rouzel Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Rouzel Pharma Private Limited
Rouzel Pharma operates one associated brand: Rouzel Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, distribution, and franchise services in India. | rouzelpharma.in |
Business Activity of Rouzel Pharma Private Limited
The main business activity of Rouzel Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rouzel Pharma Private Limited FY 2025 filings available
Rouzel Pharma Private Limited reported revenue of ₹13.56 Cr (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹13.56 Cr ▲ 8%
Net profit · FY 2024
₹22.2 Lakh margin 1.6%
EBITDA · FY 2024
₹89.59 Lakh margin 6.6%
Compounded Annual Growth Rate (CAGR) of Rouzel Pharma Private Limited
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 4%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 24%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 8% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rouzel Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹89.59 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22.2 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rouzel Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rouzel Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rouzel Pharma Private Limited
Rouzel Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Sharma Also directs: Hauz Pharma Private Limited, Sanovia Biotech Private Limited | Managing Director | 23 Mar 2011 | 15 Years 6 Months | Current |
| Vivek Singla | Director | 23 Mar 2011 | 15 Years 6 Months | Current |
Peer Comparison of Rouzel Pharma Private Limited
Rouzel Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunij Pharma Private Limited | ₹13.7 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Ahmedabad, Gujarat, India |
| Salvias Pharma Private Limited | ₹13.68 Cr (FY 2023) | •••• | •••• | 12.0% | •••• | Anakapalle, Andhra Pradesh, India |
| M Sea Pharmaceuticals Private Limited | ₹13.67 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Himachal Pradesh, India |
| Chaitanya Life Science Private Limited | ₹13.59 Cr (FY 2024) | •••• | •••• | 364.0% | •••• | Jhagadia, Gujarat, India |
| Anukar Medicals Private Limited | ₹13.57 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Somajiguda, Hyderabad-82, Telangana, India |
| Rouzel Pharma Private Limited this company | ₹13.56 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Manimajra, Chandigarh, India |
| Caplet Health Care Private Limited | ₹13.53 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Menrik Biomerge Private Limited | ₹13.52 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Dhwanilife Care Private Limited | ₹13.5 Cr (FY 2024) | •••• | •••• | 85.0% | •••• | Ahmedabad, Gujarat, India |
| Avancer Labs Private Limited | ₹13.5 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Nidus Pharma Private Limited | ₹13.5 Cr (FY 2024) | •••• | •••• | 49.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Rouzel Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rouzel Pharma Private Limited
Rouzel Pharma Private Limited is audited by SHARMA AJAY AND ASOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHARMA AJAY AND ASOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rouzel Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rouzel Pharma Private Limited
Open charges
₹1.67 Cr
Satisfied charges
₹40 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2023 | Hdfc Bank Limited | ₹1.25 Cr | Open |
| 31 Dec 2016 | Others | ₹32 Lakh | Open |
| 13 Oct 2015 | Icici Bank Limited | ₹10 Lakh | Open |
| 19 Mar 2020 | Others | ₹40 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Rouzel Pharma Private Limited
Rouzel Pharma Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Total cases
4
Filed against the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mathura, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, Shimla, Himachal Pradesh | Arbitration matter | Filed against the company by an individual | Disposed |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Rouzel Pharma Private Limited
Employment history and EPFO contributions of people linked to Rouzel Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rouzel Pharma Private Limited
Rouzel Pharma Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Vikas Sharma ceased to be Director on 01 May 2013.
AGM
Rouzel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rouzel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 19 Mar 2020 via Charge ID 100334357 with Others was fully satisfied on 29 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 125.00 Lakh with Charge ID 100714828 was registered on 20 Mar 2023.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100334357 was registered on 19 Mar 2020.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 100093579 was registered on 31 Dec 2016.
Charges
A charge with Icici Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 10627985 was registered on 13 Oct 2015.
Ceased
Vikas Sharma ceased to be Director.
Appointed
Vikas Sharma was appointed as Managing Director.
Appointed
Vivek Singla was appointed as Director.
Incorporation
23 Mar 2011
Rouzel Pharma Private Limited was registered on 23 Mar 2011 with Roc Chandigarh & aged 15 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Rouzel Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rouzel Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rouzel Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rouzel Pharma Private Limited
Rouzel Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCR2257Q1ZW | Haryana | Active | 01 Jul 2017 |
| 03AAFCR2257Q1Z2 | Punjab | Active | 18 Jul 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rouzel Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rouzel Pharma Private Limited
Rouzel Pharma is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2011 (15+ years old) and is registered under CIN U24232CH2011PTC032830.
Rouzel Pharma reported revenue of ₹13.56 Cr for FY 2024 (up 8% YoY).
Rouzel Pharma has 2 current directors:
- Vikas Sharma - Managing Director
- Vivek Singla - Director
Rouzel Pharma reported a net profit of ₹22.2 Lakh (net margin 1.6%) and EBITDA of ₹89.59 Lakh (EBITDA margin 6.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rouzel Pharma is 4% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rouzel Pharma is 06AAFCR2257Q1ZW, registered in Haryana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AAFCR2257Q1Z2 (Punjab).
The CIN (Corporate Identification Number) of Rouzel Pharma is U24232CH2011PTC032830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rouzel Pharma has 4 court cases on record: 4 filed against it. 1 is pending.
Rouzel Pharma was incorporated on 23 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Rouzel Pharma by revenue are Sunij Pharma Private Limited, Salvias Pharma Private Limited, M Sea Pharmaceuticals Private Limited, Chaitanya Life Science Private Limited, Anukar Medicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Vikas Sharma ceased to be Director on 01 May 2013. Vikas Sharma was appointed as Managing Director on 23 Mar 2011. Vivek Singla was appointed as Director on 23 Mar 2011.